Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
George Han MD, PhD

George Han MD, PhD

Associate Professor, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, New York

George Han, MD, PhD, is the Director of Research at Northwell Health Dermatology and also is Director of Teledermatology. Dr. Han is the current Vice President of the Dermatologic Society of Greater New York and a member of the Medical Board of the National Psoriasis Foundation. To date, he has two patents and over 60 publications in well-respected journals such as the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, the Journal of Infectious Diseases, and the American Journal of Pathology. Dr. Han remains active in both basic science research and clinical trials, serving as Principal Investigator in numerous clinical trials encompassing clinical area such as Psoriasis, Atopic Dermatitis, Vitiligo, and Actinic Keratosis and conducting translational research on the role of neutrophils in psoriasis.

Disclosures

Dr. Han is or has been an investigator, consultant/advisor, or speaker for Abbvie, Athenex, Boehringer Ingelheim, Bond Avillion, Bristol-Myers Squibb, Celgene, Eli Lilly, Novartis, Janssen, LEO Pharma, MC2, Ortho Dermatologics, PellePharm, Pfizer, Regeneron, Sanofi Genzyme, SUN Pharmaceuticals and UCB.

Recent Contributions to PracticeUpdate:

  1. Impact of Comorbidities on Mortality Outcomes Among Patients With Psoriasis
  2. Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
  3. Efficacy of Interleukin-17 Inhibitors in Patients With Psoriasis
  4. Alcohol Consumption and Smoking in Relation to Psoriasis
  5. Association of the Psoriatic Microenvironment With Treatment Response
  6. Utility of Repeat Latent Tuberculosis Testing With QuantiFERON-TB Gold Test in Psoriasis Patients Treated With TNF-α Inhibitors
  7. Dermatologic Care of Uninsured Patients Managed at Free Clinics
  8. Maintenance of Skin Clearance With Ixekizumab Treatment of Psoriasis
  9. Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma in Situ

Most Read This Week

Recently Updated